文献速递心脑血管急症重症综合管理与镇静镇痛

KEEP SIMPLEST研究:减少卒中取栓术院内延迟及围手术期管理——匹配配对分析

The KEEP SIMPLEST Study: Improving In-House Delays and Periinterventional Management in Stroke Thrombectomy-A Matched Pair Analysis.
PubMed 文献 · Neurocrit Care · 2019-01-01
一句话结论采用艾司氯胺酮联合丙泊酚清醒镇静的新SOP可显著缩短卒中取栓的院内延迟,且安全可行。

KEEP SIMPLEST为前瞻性单中心观察性研究,比较按新SOP(艾司氯胺酮联合丙泊酚镇静)治疗的急性缺血性卒中取栓患者与SIESTA试验中随机分入清醒镇静组的患者。新SOP组在到院至再通时间、取栓平均时长、到院至首次造影图像时间及CT至首次造影图像时间上均显著短于对照组,而24小时早期神经功能改善、3个月改良Rankin量表评分及其他次要结局无差异,两组清醒镇静转全麻率相似。结论认为该SOP可显著减少院内治疗延迟并展示安全性与可行性。

要点

  • 新SOP组到院至再通时间128.6±69.47分钟 vs 对照组156.8±75.91分钟,显著缩短(p=0.02)。
  • 新SOP组取栓平均时长92.01±52分钟 vs 对照组131.9±64.03分钟,显著缩短(p<0.001)。
  • 新SOP组到院至首次造影图像时间51.61±31.7分钟 vs 对照组64.23±21.53分钟,显著缩短(p=0.003)。
  • 新SOP组CT至首次造影图像时间31.61±20.6分钟 vs 对照组44.61±19.3分钟,显著缩短(p<0.001)。
  • 两组24小时早期神经功能改善、3个月mRS及其他次要结局无差异,清醒镇静转全麻率相似。

适用人群与场景

  • 接受机械取栓的急性缺血性卒中患者,采用轻度镇静(清醒镇静)者。

处置流程与药物剂量

  • 新SOP采用艾司氯胺酮联合丙泊酚的镇静方案,并优化设备与流程,旨在实现更精简、整合和紧凑的围手术期管理。

研究设计与关键结果

  • 前瞻性单中心观察性研究,比较按新SOP治疗的急性缺血性卒中取栓患者与SIESTA试验中随机分入清醒镇静组的患者。
  • 主要终点为24小时采用美国国立卫生研究院卒中量表评估的早期神经功能改善,两组无差异。
  • 次要终点中,新SOP组到院至再通时间128.6±69.47分钟 vs 对照组156.8±75.91分钟(p=0.02),取栓平均时长92.01±52分钟 vs 131.9±64.03分钟(p<0.001),到院至首次造影图像时间51.61±31.7分钟 vs 64.23±21.53分钟(p=0.003),CT至首次造影图像时间31.61±20.6分钟 vs 44.61±19.3分钟(p<0.001),均显著缩短。
  • 3个月改良Rankin量表评分及其他次要结局两组无差异,清醒镇静转全麻率相似。

证据类型、等级与局限

  • 证据类型:前瞻性单中心观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,采用新型镇静方案并优化设备与流程、 directed at 更精简、整合和紧凑的围手术期管理的SOP,可显著减少接受轻度镇静取栓的卒中患者的院内治疗延迟,并展示了改进方法的安全性和可行性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Although the treatment window for mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) has been extended in recent years, it has been proven that recanalizing treatment must be administered as soon as possible. We present a new standard operating procedure (SOP) to reduce in-house delay, standardize periinterventional management and improve patient safety during MT.

METHODS: KEep Evaluating Protocol Simplification In Managing Periinterventional Light Sedation for Endovascular Stroke Treatment (KEEP SIMPLEST) was a prospective, single-center observational study aimed to compare aspects of periinterventional management in AIS patients treated according to our new SOP using a combination of esketamine and propofol with patients having been randomized into conscious sedation (CS) in the Sedation versus Intubation for Endovascular Stroke TreAtment (SIESTA) trial. Primary outcome was early neurological improvement at 24h using the National Institutes of Health Stroke Scale, and secondary outcomes were door-to-recanalization, recanalization grade, conversion rate and modified Rankin Scale (mRS) at 3 months.

RESULTS: Door-to-recanalization time (128.6 ± 69.47 min vs. 156.8 ± 75.91 min; p = 0.02), mean duration of MT (92.01 ± 52 min vs. 131.9 ± 64.03 min; p < 0.001), door-to-first angiographic image (51.61 ± 31.7 min vs. 64.23 ± 21.53 min; p = 0.003) and computed tomography-to-first angiographic image time (31.61 ± 20.6 min vs. 44.61 ± 19.3 min; p < 0.001) were significantly shorter in the group treated under the new SOP. There were no differences in early neurological improvement, mRS at 3 months or other secondary outcomes between the groups. Conversion rates of CS to general anesthesia were similar in both groups.

CONCLUSION: An SOP using a novel sedation regimen and optimization of equipment and procedures directed at a leaner, more integrative and compact periinterventional management can reduce in-house treatment delays significantly in stroke patients receiving thrombectomy in light sedation and demonstrated the safety and feasibility of our improved approach.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Schönenberger S, Weber D, Ungerer MN, et al. The KEEP SIMPLEST Study: Improving In-House Delays and Periinterventional Management in Stroke Thrombectomy-A Matched Pair Analysis. Neurocrit Care. 2019. PMID: 30659468. doi:10.1007/s12028-018-00667-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。